parkinson glutathione oxidative ipsc crispr

parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Frontiers | Development of CRISPR

Name: parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Frontiers | Development of CRISPR
Brand: lagence-mr.com
SKU: 53158251939
Price: 26.48 USD
Availability: InStock
Rating: 4.381600000000001 (17 reviews)

Frontiers Development of CRISPR Cas9, spin off technologies and their application in model construction and potential therapeutic methods of Parkinson's disease Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing ScienceDirect Glutathione S transferase: A keystone in Parkinson's disease pathogenesis and therapy ScienceDirect Decoding Parkinson's Disease: The interplay of cell death pathways, oxidative stress, and therapeutic innovations PMC Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells PMC

SKU: 53158251939 · From lagence-mr.com

4.4

USD26.48 USD51.48

Pay in 4 interest-free payments of $6.62 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 23 - Sep 28

Description

For example, it has been reported that eMSCs inhibit the Wnt/-catenin signaling pathway by secreting dickkopf-1-related proteins, which in turn suppresses the proliferation and stemness of EC cells